Abstract:Understanding mechanisms of ageing remains a complex challenge for biogerontologists, but recent adaptations of evolutionary ageing theories offer a compelling lens in which to view both age-related molecular and physiological deterioration. Ageing is commonly associated with progressive declines in biochemical and molecular processes resulting from damage accumulation, yet the role of continued developmental gene activation is less appreciated. Natural selection pressures are at their highest in youthful periods to modify gene expression towards maximising reproductive capacity. After sexual maturation, selective pressure diminishes, subjecting individuals to maladaptive pleiotropic gene functions that were once beneficial for developmental growth but become pathogenic later in life. Due to this selective 'shadowing' in ageing, mechanisms to counter such hyper/hypofunctional genes are unlikely to evolve. Interventions aimed at targeting gene hyper/hypofunction during ageing might, therefore, represent an attractive therapeutic strategy. The nematode Caenorhabditis elegans offers a strong model for post-reproductive mechanistic and therapeutic investigations, yet studies examining the mechanisms of, and countermeasures against, ageing decline largely intervene from larval stages onwards. Importantly, however, lifespan extending conditions frequently impair early-life fitness and fail to correspondingly increase healthspan. Here, we consolidate multiple evolutionary theories of ageing and discuss data supporting hyper/hypofunctional changes at a global molecular and functional level in C. elegans, and how classical lifespan-extension mutations alter these dynamics. The relevance of such mutant models for exploring mechanisms of ageing are discussed, highlighting that post-reproductive gene optimisation represents a more translatable approach for C. elegans research that is not constrained by evolutionary trade-offs. Where some genetic mutations in C. elegans that promote late-life health map accordingly with healthy ageing in humans, other widely used genetic mutations that extend worm lifespan are associated with life-limiting pathologies in people. Lifespan has also become the gold standard for quantifying 'ageing', but we argue that gerospan compression (i.e., 'healthier' ageing) is an appropriate goal for anti-ageing research, the mechanisms of which appear distinct from those regulating lifespan alone. There is, therefore, an evident need to re-evaluate experimental approaches to study the role of hyper/hypofunctional genes in ageing in C. elegans.

Decoding Aging: Examining the Non-Evolutionary Event from an Evolutionary Perspective

Aging:A Life Science Approach

An evaluation of aging measures: from biomarkers to clocks

A unified framework for evolutionary genetic and physiological theories of aging

The landscape of aging

Emerging epigenetic insights into aging mechanisms and interventions

Minireview: What Evolutionary Biology Can Do for Gerontology

A complex systems approach to aging biology

The Evolutionary Stage of Cognitive Frailty and Its Changing Characteristics in Old Adults

Developmental Drift and the Role of Wnt Signaling in Aging

Ageing and the goal of evolution

Evolution of ageing as a tangle of trade-offs: energy versus function

Systems Biology in Aging: Linking the Old and the Young.

How evolution makes us age: Introducing the evolvable soma theory of ageing

Why evolution needs the old: a theory of ageing as adaptive force

Consolidating multiple evolutionary theories of ageing suggests a need for new approaches to study genetic contributions to ageing decline

An Aging Program at the Systems Level?

An In Silico Model to Simulate the Evolution of Biological Aging

Keeping up with the Red Queen: the pace of aging as an adaptation

Ageing as a two-phase process: theoretical framework

Mammal Aging as a Programmed Life Cycle Function - Resolving the Cause and Effect Conundrum